SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-025063
Filing Date
2021-11-03
Accepted
2021-11-03 12:06:10
Documents
16
Period of Report
2021-11-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20211103_8k.htm   iXBRL 8-K 29862
2 EXHIBIT 99.1 ex_301698.htm EX-99.1 11002
7 ex_301698img001.jpg GRAPHIC 13877
8 logo01.jpg GRAPHIC 9343
  Complete submission text file 0001437749-21-025063.txt   213388

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nby-20211103.xsd EX-101.SCH 3585
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20211103_def.xml EX-101.DEF 11804
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20211103_lab.xml EX-101.LAB 15858
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20211103_pre.xml EX-101.PRE 12019
9 EXTRACTED XBRL INSTANCE DOCUMENT nby20211103_8k_htm.xml XML 2655
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 211374385
SIC: 2834 Pharmaceutical Preparations